{"id":"cceb6769-ad20-5dc9-8af6-bdb56cfedb94","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-a-quarter-tablet","predicate":"reduces","statement":"In rabbits lower doses of aspirin produced major inhibition of platelet aggregation and minor inhibition of prostacyclin synthesis while higher doses inhibited both, in humans a dose equivalent to approximately one quarter of one 300 milligram tablet consistently produced major inhibition of cyclooxygenase-dependent platelet aggregation in a pattern similar to that in rabbits where most prostacyclin synthetic capacity was not inhibited, and it took rabbit vasculature over 24 hours to return to control prostacyclin synthetic capacity after a single high dose.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"0ebbd068-d894-5866-ba6c-16d9c914cbc3","mechanism_event_label":"About a quarter of a tablet stops the platelets while mostly leaving the vessel wall alone.","subject":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"object":{"id":"a65aa8a9-a3a0-524d-904a-28bc1c42bd05","slug":"platelet-aggregation-asa","display_name":"Cyclooxygenase-dependent platelet aggregation","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"0ebbd068-d894-5866-ba6c-16d9c914cbc3","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-a-quarter-tablet-event","event_type":"observed_intervention","label":"About a quarter of a tablet stops the platelets while mostly leaving the vessel wall alone.","description":"In rabbits lower doses of aspirin produced major inhibition of platelet aggregation and minor inhibition of prostacyclin synthesis while higher doses inhibited both, in humans a dose equivalent to approximately one quarter of one 300 milligram tablet consistently produced major inhibition of cyclooxygenase-dependent platelet aggregation in a pattern similar to that in rabbits where most prostacyclin synthetic capacity was not inhibited, and it took rabbit vasculature over 24 hours to return to control prostacyclin synthetic capacity after a single high dose.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"429b3d06-eaed-54e6-9444-48a98a537ed0","slug":"vessel-wall-prostacyclin","display_name":"Prostacyclin synthesis by the vessel wall","entity_type_key":"cellular_process"},"role":"partially_spared","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"25063538-7b79-5cd4-9839-511490482e03","slug":"prostacyclin","display_name":"Prostacyclin / prostaglandin I2","entity_type_key":"small_molecule"},"role":"measured_product","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"a65aa8a9-a3a0-524d-904a-28bc1c42bd05","slug":"platelet-aggregation-asa","display_name":"Cyclooxygenase-dependent platelet aggregation","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/6156337.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e0d904fae5d8c006bd180213b6b2cbc88c87bb103b9c8b8872705330c349b074\", \"start_char\": 0, \"end_char\": 1502, \"text_sha256\": \"e0d904fae5d8c006bd180213b6b2cbc88c87bb103b9c8b8872705330c349b074\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Human and rabbit platelet aggregation with rabbit aortic prostacyclin synthesis measured across aspirin doses","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Graded oral aspirin doses, sampled three hours after dosing, with recovery followed over 24 hours in rabbits","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Sets the dose at which the two tissues start to separate, but the vascular arm is rabbit aorta and the human arm measures aggregation rather than prostacyclin.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human and rabbit","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"About a quarter of a tablet stops the platelets while mostly leaving the vessel wall alone.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p6156337] Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits. (1980). https://pubmed.ncbi.nlm.nih.gov/6156337/ DOI: 10.1097/00005344-198007000-00006","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Platelets and aorta","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"5d250bdc-ccb2-510a-880f-510bf0075e05","evidence_kind":"source_excerpt","locator":"Lines 390-401","start_line":390,"end_line":401,"excerpt":"### asa-a-quarter-tablet\nIn rabbits lower doses of aspirin produced major inhibition of platelet aggregation and minor inhibition of prostacyclin synthesis while higher doses inhibited both, in humans a dose equivalent to approximately one quarter of one 300 milligram tablet consistently produced major inhibition of cyclooxygenase-dependent platelet aggregation in a pattern similar to that in rabbits where most prostacyclin synthetic capacity was not inhibited, and it took rabbit vasculature over 24 hours to return to control prostacyclin synthetic capacity after a single high dose.\nCondition category: normal\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: About a quarter of a tablet stops the platelets while mostly leaving the vessel wall alone.\norganism: Human and rabbit\ntissue_or_cell_type: Platelets and aorta\nexperimental_model: Human and rabbit platelet aggregation with rabbit aortic prostacyclin synthesis measured across aspirin doses\nlimitations: Sets the dose at which the two tissues start to separate, but the vascular arm is rabbit aorta and the human arm measures aggregation rather than prostacyclin.\nexposure: Graded oral aspirin doses, sampled three hours after dosing, with recovery followed over 24 hours in rabbits\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/6156337.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"e0d904fae5d8c006bd180213b6b2cbc88c87bb103b9c8b8872705330c349b074\", \"start_char\": 0, \"end_char\": 1502, \"text_sha256\": \"e0d904fae5d8c006bd180213b6b2cbc88c87bb103b9c8b8872705330c349b074\"}\n[asa-p6156337] Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits. (1980). https://pubmed.ncbi.nlm.nih.gov/6156337/ DOI: 10.1097/00005344-198007000-00006","model_system":"Human and rabbit platelet aggregation with rabbit aortic prostacyclin synthesis measured across aspirin doses","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p6156337] Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits. (1980). https://pubmed.ncbi.nlm.nih.gov/6156337/ DOI: 10.1097/00005344-198007000-00006","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}